Live Investment Opportunity | Minimum $100 | $94,400+ Already Raised

The World's First Multi-Drug Breathalyzer Is Saving Lives And You Can Be Part of It

Epinal is revolutionizing public safety with breakthrough breath-detection technology that identifies narcotics in minutes — not days. Join 27+ investors backing the future of drug testing.

Invest Now

Get Campaign Updates

Receive field-trial news, partnerships, and
funding progress

Phone

Email *

Privacy Policy | Terms of Service

Meet Mark Wong CEO & Co-Founder

I spent 20 years building companies in the tech and semiconductor industries. But nothing has felt as urgent or as important as Epinal.

My co-founder Mike and I started Epinal because we saw a terrifying gap in public safety there was no way to rapidly detect narcotics in the field. Law enforcement officers were making life-or-death decisions without real-time data. Families were losing loved ones to overdoses because emergency responders couldn't identify the substances fast enough. Employers were waiting days for drug test results while impaired workers put everyone at risk.

We knew technology could solve this.

After 5+ years of R&D and working with some of the brightest minds in biosensor technology, we've created Narcolyzer™ the world's first portable, multi-drug breathalyzer. It detects opioids, THC, cocaine, methamphetamine, and more in under 5 minutes.

This isn't just a business. It's a mission to save lives.

We've already raised over $94,000 from 27+ investors who believe in what we're building. Law enforcement agencies in 8+ states are asking for our technology. And we're preparing for FDA-approved field trials in 2026.

But we need your help to get there.

Whether you invest $100 or $10,000, you're not just backing a company you're backing a technology that will prevent tragedies, protect communities, and change the way we think about drug testing forever. Join us.

Mark Wong
CEO & Co-Founder, Epinal Inc.

Invest Now

Get Campaign Updates

Receive field-trial news, partnerships, and
funding progress

Phone

Email *

Privacy Policy | Terms of Service

CEO and co-founder of Epinal.

Hi, I'm Mark Wong, CEO and co-founder of Epinal.

Five years ago, my co-founder Mike and I asked ourselves a question Why is there no breathalyzer for narcotics?

We have alcohol breathalyzers. But when it comes to opioids, cocaine, THC substances killing thousands every year law enforcement has to wait days for lab results. Emergency responders can't identify what's causing an overdose in time to save lives. Employers are hiring people without knowing if they're impaired.

The Crisis We're Solving

Drug-impaired driving, workplace accidents, and overdose deaths are at an all-time high. But the tools to detect narcotics are decades behind.

The Impaired Driving Epidemic

40,000+ people die annually in drug-related traffic accidents in the U.S. alone. Law enforcement lacks real-time roadside tools to detect narcotics — meaning impaired drivers often go undetected until it's too late.

Workplace Safety at Risk

Employers in high-risk industries face delays of 3–7 days for lab testing. The result? Lost productivity, higher liability, and unsafe conditions. Companies need real-time results — not lab delays.

The Overdose Crisis

Over 100,000 Americans die from overdoses annually. Without knowing which drug caused it, first responders lose precious minutes. Narcolyzer identifies substances in under 5 minutes — enabling faster, life-saving care.

SEE HOW NARCOLYZER SOLVES THIS

The World's First Portable, Multi-Drug Breathalyzer

Non-invasive. Real-time results. Life-saving technology.

Narcolyzer is a breakthrough handheld breathalyzer that detects multiple narcotics simultaneously through a simple breath test. No needles. No urine cups. No waiting days for lab results. Just breathe — and get answers in minutes.

Our proprietary bio-inspired sensor technology mimics the molecular recognition systems found in nature, enabling accurate detection of:

THC & THC-A (marijuana)
Opiates (heroin, morphine, codeine)
Cocaine
Benzodiazepines (Xanax, Valium)
MDMA (Ecstasy)
Methamphetamine
And their derivatives

Step 1: Insert Sensor Cartridge

Our removable, one-time-use sensor cartridge slides into the Narcolyzer device in seconds.

Step 2: Breathe Into Device

The user provides a simple 30-second breath sample — non-invasive and dignified.

Step 3: Get Instant Results

Within 3-5 minutes, results appear on-screen with biometric data retention for documentation.

INVEST IN NARCOLYZER TODAY

Who’s Asking for Narcolyzer

Who's Asking for Narcolyzer?

From law enforcement to Fortune 500 companies, the demand is overwhelming.

🚔 Law Enforcement & First Responders

The Need: Police need real-time roadside testing for narcotic impairment. Current lab-based methods delay arrests.

Narcolyzer's Impact: Enables instant detection at stops and crime scenes — providing evidence that saves lives.

Early Adopters: California Highway Patrol, Texas DPS, and more.

🏗️ Workplace Safety & HR Compliance

The Need: Employers in high-risk sectors wait days for lab results — delaying hiring and risking safety.

Narcolyzer's Impact: Enables on-site drug screening with instant results and reduced liability.

Target Customers: Fortune 500 manufacturers, logistics firms, oil & gas operators.

🚛 Transportation & Fleet Management

The Need: DOT-compliant testing currently causes costly downtime for fleets.

Narcolyzer's Impact: Enables pre-shift or post-incident testing without disrupting operations.

Target Customers: Trucking fleets, transit agencies, ride-share companies.

✈️ Aviation & Aerospace Safety

The Need: Flight readiness testing can delay schedules when reliant on labs.

Narcolyzer's Impact: Conduct rapid pre-flight screenings in minutes.

Target Customers: Airlines, private aviation operators, aerospace contractors.

🎖️ Military & Defense Readiness

The Need: Drug screening for deployment and security clearance is slow in remote zones.

Narcolyzer's Impact: Portable and field-ready testing ensures mission readiness.

Target Customers: DoD, Special Ops, defense contractors.

🏠 At-Home Testing & Family Safety

The Need: Parents and recovery programs need private, non-invasive monitoring tools.

Narcolyzer's Impact: Empowers families and recovery centers with instant, stigma-free results.

Target Customers: Parents, recovery programs, treatment centers.

INVEST IN NARCOLYZER TODAY

Testimonials:

FAQ Section - KickGoalz

Frequently Asked Questions

What is a SAFE, and how does it work?

A SAFE (Simple Agreement for Future Equity) is an investment contract that gives you the right to receive equity shares in Epinal at a future date typically when the company raises its next priced funding round (Series A, Series B) or undergoes a liquidity event (acquisition or IPO).

What is the minimum investment?

The minimum investment is $100. There is no maximum limit you can invest as much as you're comfortable with, up to the campaign's $2M maximum raise

How do I make money from this investment?

You make money when Epinal undergoes a liquidity event, such as: Acquisition: A larger company (e.g., Abbott, Dräger, Thermo Fisher) acquires Epinal. Your SAFE converts to equity, and you receive cash or stock based on the acquisition terms. IPO: Epinal goes public, and your shares become tradeable on public markets. Secondary sale: In some cases, investors may have opportunities to sell shares in private secondary markets before an IPO (typically after Series B/C rounds).

What are the risks of investing in Epinal?

Like all early-stage investments, investing in Epinal carries significant risk. Potential risks include: Product development delays: FDA approval and field trial timelines may take longer than expected. Regulatory challenges: Medical device approval processes are complex and uncertain. Market adoption: Customers may be slower to adopt new technology than projected. Competition: Larger companies could enter the market with competing products. Funding risk: Epinal may need to raise additional capital, which could dilute your ownership.

When will Narcolyzer be available for purchase?

We are currently in the R&D and field trial phase. Our projected timeline is: 2026: Complete multi-state field trials and submit FDA application 2027: Achieve FDA clearance and launch limited commercial production 2028: Scale manufacturing and begin widespread sales

Is my investment tax-deductible?

No. Investments in Epinal are equity investments, not charitable donations, and are therefore not tax-deductible. However, you may be eligible for certain tax benefits under the Qualified Small Business Stock (QSBS) exemption if Epinal meets IRS criteria and you hold shares for 5+ years. Consult a tax advisor for details.